Increased TNFα production and Cox-2 activity in organotypic brain slice cultures from APPsw transgenic mice

Neuroscience Letters

Volumn 353, Issue 1, 2003, Pages 66-68

  Quadros, Amita ^a   Patel, Nikunj ^a   Crescentini, Robert ^a   Crawford, Fiona ^a   Paris, Daniel ^a   Mullan, Michael ^a  

^a ROSKAMP INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Cyclooxygenase 2; Inflammation; Prostaglandin E2; Transgenic APP Swedish mice; Tumor necrosis factor

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CYCLOOXYGENASE 2; ICOSANOID; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

AGE; ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0344420111     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.08.076     Document Type: Article

References (19)

1. Bamberger M.E., Landreth G.E. Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist. 8:2002;276-283.
2. Casal C., Serratosa J., Tusell J.M. Relationship between beta-AP peptide aggregation and microglial activation. Brain Res. 928:2002;76-84.
3. Chen C., Magee J.C., Bazan N.G. Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J. Neurophysiol. 87:2002;2851-2857.
4. Dannhardt G., Kiefer W. Cyclooxygenase inhibitors - current status and future prospects. Eur. J. Med. Chem. 36:2001;109-126.
5. Eikelenboom P., Bate C., Van Gool W.A., Hoozemans J.J., Rozemuller J.M., Veerhuis R., Williams A. Neuroinflammation in Alzheimer's disease and prion disease. Glia. 40:2002;232-239.
6. Furukawa K., Mattson M.P. The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons. J. Neurochem. 70:1998;1876-1886.
7. Gasic-Milenkovic J., Dukic-Stefanovic S., Deuther-Conrad W., Gartner U., Munch G. beta-Amyloid peptide potentiates inflammatory responses induced by lipopolysaccharide, interferon-gamma and 'advanced glycation endproducts' in a murine microglia cell line. Eur. J. Neurosci. 17:2003;813-821.
8. Ho L., Purohit D., Haroutunian V., Luterman J.D., Willis F., Naslund J., Buxbaum J.D., Mohs R.C., Aisen P.S., Pasinetti G.M. Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch. Neurol. 58:2001;487-492.
9. Kuo Y.M., Beach T.G., Sue L.I., Scott S., Layne K.J., Kokjohn T.A., Kalback W.M., Luehrs D.C., Vishnivetskaya T.A., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., Weller R.O., Roher A.E. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease. Mol. Med. 7:2001;609-618.
10. Lee Y.B., Schrader J.W., Kim S.U. p38 map kinase regulates TNF-alpha production in human astrocytes and microglia by multiple mechanisms. Cytokine. 12:2000;874-880.
11. McGeer E.G., McGeer P.L. The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33:1998;371-378.
12. Neumann H., Schweigreiter R., Yamashita T., Rosenkranz K., Wekerle H., Barde Y.A. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J. Neurosci. 22:2002;854-862.
13. Paris D., Townsend K.P., Obregon D.F., Humphrey J., Mullan M. Pro-inflammatory effect of freshly solubilized beta-amyloid peptides in the brain. Prostaglandins Other Lipid Mediat. 70:2002;1-12.
14. Pober J.S. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells. Ciba Found Symp. 131:1987;170-184.
15. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G. TNF-alpha transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:1997;137-141.
16. Vehmas A.K., Kawas C.H., Stewart W.F., Troncoso J.C. Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol. Aging. 24:2003;321-331.
17. Weggen S., Eriksen J.L., Das P., Sagi S.A., Wang R., Pietrzik C.U., Findlay K.A., Smith T.E., Murphy M.P., Bulter T., Kang D.E., Marquez-Sterling N., Golde T.E., Koo E.H. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 414:2001;212-216.
18. Wilcock G.K., Esiri M.M. Plaques, tangles and dementia. A quantitative study. J. Neurol. Sci. 56:1982;343-356.
19. Xiang Z., Ho L., Yemul S., Zhao Z., Qing W., Pompl P., Kelley K., Dang A., Qing W., Teplow D., Pasinetti G.M. Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology. Gene Expr. 10:2002;271-278.